Isis: I really hope that you are not one of those affected by this, but if you are, do not worry, you will be helped.
Researchers at the New York University (NYU) Langone Medical Center (LMC) have released a study claiming that an excess of 2/3rds of the US population are carrying the human papillomavirus (HPV) “on some part of their body”.
Data for this study was provided by the National Institutes of Health (NIH).
Funding for this project was provided by:
• NIH Roadmap Initiative’s Human Microbiome Project
• National Cancer Institute
• NIH Office of Research and Development
• Veterans Health Administration
• US Department of Veterans Affairs.
The researchers identified “109 strains of HPV out of 148 known strains” and showed it was common place for HPV to infect the skin of 61% of the study participants.
Forty-one percent of those studied had vaginal HPV infections, 30% had oral infections and 17% had gut infections.
Researchers stated that the majority of these infections “are likely harmless” because the volunteers did not display “symptoms of illness”.
Recorded in the study, it was shown that only 4% of the participants have HPV-16 or HPV-18; the strains assumed to cause cervical cancers.
Treatment for HPV is the Gardasil vaccine manufactured by Merck Pharmaceuticals.
Shockingly, information in the insert for Gardasil states that the vaccine has not been tested for carcinogenicity.
Indeed, there is no evidentiary reason for Gardasil to be used to combat HPV or as a preventative for reproductive cancers.
According to Dr. Charlotte Haug on the validity of Gardasil: “There is another serious question that may be answered sooner: what effect will the vaccine have on the other cancer-causing strains of HPV? Nature never leaves a void, so if HPV-16 and HPV-18 are suppressed by an effective vaccine, other strains of the virus will take their place. The question is, will these strains cause cervical cancer?”
Haug continues: “Results from clinical trials are not encouraging. Vaccinated women show an increased number of precancerous lesions caused by strains of HPV other than HPV-16 and HPV-18. The results are not statistically significant, but if the trend is real – and further clinical trials should tell us in a few years – there is reason for serious concern.”
Studies have shown there has been a palatiable increase in those who are exposed to HPV who have also received the Gardasil vaccine to develop cancer.
It was found that in “peer-reviewed analysis and studies many of them on the FDA, NCI and CDC web sites point out the dangers of many of the vaccine ingredients including the potential for the HPV vaccines to increase the risk for pre-cancerous lesions if adolescents have been previously exposed to the human papillomavirus and then get vaccinated: 44.6% increase post Gardasil.”
Most shocking is that in a test taken from 13 samples of Gardasil, it was discovered that “all the samples contained recombinant (genetically modified) HPV DNA which was firmly attached to the aluminum adjuvant.”
This recombinant HPV DNA is considered bio-hazardous with effects unknown to the medical community.
It was stated : “Based on medical literature and some of the FDA/Merck’s own publications, adventitious (coming from an outside source) DNA in an injectable protein-based vaccine may increase the risk of autoimmune disorders and gene mutation which may lead to malignancies.”